Please use this identifier to cite or link to this item:
Title: Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data
Author: Gershman, Mark D.
Staples, J.Erin
Bentsi-Enchill, Adwoa D.
Breugelmans, J.Gabrielle
Brito, Glacus S.
Bastos Camacho, Luiz A.
Cottin, Pascale
Domingo, Cristina
Durbin, Anna
Gascon, Joaquim
Guenaneche, Fouzia
Hayes, Edward B.
Jelenik, Zsuzsanna
Khromava, Alena
Menezes Martins, Reinaldo de
Masana Wilson, Mario
Massy, Nathalie
Nasidi, Abdulsalami
Niedrig, Matthias
Sherwat, Adam
Tsai, Theodore
Vilella i Morató, Anna
Wilson, Mary Elisabeth
Kohl, Katrin S.
The Brighton Collaboration Viscerotropic Disease Working Group
Keywords: Vacunació
Efectes secundaris dels medicaments
Drug side effects
Issue Date: 13-Jul-2012
Publisher: Elsevier B.V.
Abstract: Viscerotropic disease (VTD) is defined as acute multiple organ system dysfunction that occurs following vaccination. The severity of VTD ranges from relatively mild multisystem disease to severe multiple organ system failure and death. The term VTD was first used shortly after the initial published reports in 2001 of febrile multiple organ system failure following yellow fever (YF) vaccination. To date, VTD has been reported only in association with YF vaccine and has been thus referred to as YF vaccine-associated viscerotropic disease (YEL-AVD).
Note: Versió postprint del document publicat a:
It is part of: Vaccine, 2012, vol. 30, num. 33, p. 5038-5058
Related resource:
ISSN: 0264-410X
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
618829.pdf1.02 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.